Opus Genetics (NASDAQ:IRD) Shares Up 2% – What’s Next?

Opus Genetics, Inc. (NASDAQ:IRD)’s share price was up 2% on Friday . The company traded as high as $1.06 and last traded at $1.01. Approximately 187,892 shares were traded during trading, a decline of 15% from the average daily volume of 220,116 shares. The stock had previously closed at $0.99.

Analyst Ratings Changes

Separately, HC Wainwright restated a “buy” rating and set a $8.00 price objective on shares of Opus Genetics in a research report on Wednesday, February 19th.

Opus Genetics Stock Up 2.0 %

The stock’s 50 day moving average price is $1.08. The firm has a market capitalization of $32.37 million, a price-to-earnings ratio of -0.93 and a beta of 0.28.

Opus Genetics Company Profile

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc, formerly known as Ocuphire Pharma Inc, is based in Farmington Hills, Michigan.